Stocks
Astellas Pharma Inc.ALPMY
OTCHealthcareBiotechnology$14.66-0.74%
A global pharmaceutical company focused on developing and commercializing innovative therapies, particularly in oncology, urology, and immunology. With a robust pipeline and strategic partnerships, it is a key player in addressing unmet medical needs, making it a notable stock for healthcare investors.
Market Cap: $26.3B52W Range: $8.37 – $16.95
Congressional Interest in Astellas Pharma Inc. (ALPMY)
6 members of Congress have disclosed 22 trades in Astellas Pharma Inc. (ALPMY), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
22
Unique Politicians
6
Buys
13
Sells
9
Who in Congress Is Trading ALPMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | buy | $15K – $50K |